IRD logo

IRD

Opus Genetics Inc.

$5.09
+$0.17(+3.46%)
43
Overall
40
Value
58
Tech
31
Quality
How is this score calculated?
Market Cap
$124.01M
Volume
621.82K
52W Range
$0.65 - $5.30
Target Price
$9.93

Latest News for IRD

Rocket Doctor AI Expands Into Maryland, Names New Medical Lead to Drive U.S. Growth
TipRanks Canadian Auto-Generated Newsdesk2 hours agoApr 08, 2026

An update from Rocket Doctor AI ( ($TSE:AIDR) ) is now available. Rocket Doctor AI has launched patient care operations in Maryland through its who......

Bird Construction Sets May 13 Release, May 14 Call for Q1 2026 Results
TipRanks Canadian Auto-Generated Newsdeska day agoApr 07, 2026

An update from Bird Construction ( ($TSE:BDT) ) is now available. Bird Construction Inc. said it will release its 2026 first-quarter financial resu......

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Opus Genetics (IRD)
Howard Kim2 days agoApr 07, 2026

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurosense Therapeutics Ltd. (NRSN) and Opus Genetic......

Opus Genetics Secures Major Non-Dilutive Funding Facility
TipRanks Auto-Generated Newsdesk2 days agoApr 07, 2026

Opus Genetics ( ($IRD) ) just unveiled an update. On April 2, 2026, Opus Genetics entered into a senior secured note purchase agreement providing a......

Morning News Wrap-Up 4/2/26: Today’s Biggest Stock Market Stories!
William White6 days agoApr 02, 2026

Investors will find the hottest stock market stories ready to go in our daily wrap-up for Thursday. ...

Kepler Capital Remains a Buy on Viridien (0RI9)
TipRanks Auto-Generated Intelligence Newsdesk20 days agoMar 20, 2026

In a report released on March 18, Kevin Roger from Kepler Capital maintained a Buy rating on Viridien, with a price target of €180.00. The company’......

Rocket Doctor AI Raises $2.05 Million from Warrant Exercises to Fund AI Health Expansion
TipRanks Canadian Auto-Generated Newsdesk22 days agoMar 17, 2026

An update from Rocket Doctor AI ( ($TSE:AIDR) ) is now available. Rocket Doctor AI Inc., a Vancouver-based provider of AI-powered healthcare techno......

Bird Construction (BDT) Receives a Buy from CIBC
TipRanks Auto-Generated Intelligence Newsdeska month agoMar 13, 2026

In a report released today, Krista Friesen from CIBC maintained a Buy rating on Bird Construction, with a price target of C$40.00. Friesen covers t......

Viatris-Backed Nyxol Trial Completes Phase 3, Setting Up a Key Night-Vision Catalyst
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoMar 12, 2026

Viatris, Inc. ($VTRS), Opus Genetics, Inc. ($IRD) announced an update on their ongoing clinical study. The study, officially titled “Randomized, Pl......

Ocuphire’s Nyxol Presbyopia Trial Nears Data: What Investors Should Watch
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoMar 12, 2026

Opus Genetics, Inc. ($IRD) announced an update on their ongoing clinical study. The Phase 3 study “Randomized, Double-masked, Placebo-controlled, M......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 15 articles.

ABCD
1SymbolPriceChangeVol
2IRD$5.09+3.5%621.82K
3
4
5
6

Get Opus Genetics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.